Fibrosis-4 Index at Diagnosis is Associated with All-cause Mortality in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
Overview
Affiliations
Background: The fibrosis-4 index (FIB-4) has been reported to be associated with all-cause mortality in several chronic diseases. In this study, we investigated whether at diagnosis could be associated with all-cause mortality in patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA).
Methods: We retrospectively reviewed the medical records of 132 MPA and GPA patients without chronic liver diseases. Conventional risk factors included old age (≥ 65 years), male gender, diabetes mellitus (DM) and hypertension (HTN) at diagnosis, and disease-related risk factor included GPA, antineutrophil cytoplasmic antibody, Birmingham vasculitis activity score (BVAS) and five factor score (FFS (2009)). The cut-off of FIB-4 for significant liver fibrosis (S2-4) was set at 1.45.
Results: The mean age was 57.2 years and 27 patients (20.5%) had significant liver fibrosis (FIB-4 ≥ 1.45). Fifteen patients (11.4%) died during follow-up. In the univariable Cox Hazards model, age ≥ 65 years (Hazard ratio (HR) 5.055), DM (HR 3.446), HTN (HR 4.611), FFS (2009) ≥ 2 (HR 4.849) and FIB-4 ≥ 1.45 (HR 9.958) at diagnosis were significantly associated with all-cause mortality. In the multivariable Cox Hazards model, only FIB-4 at diagnosis ≥1.45 (HR 6.253, 95% confidence interval 1.398, 27.963) was associated with all-cause mortality during the follow-up in patients with MPA and GPA.
Conclusions: FIB-4 at diagnosis ≥1.45 is an independent predictor of all-cause mortality during follow-up in patients with MPA and GPA, and furthermore its predictive potential is higher than those of conventional and AAV-related risk factors for all-cause mortality.
Yamashita S, Takase H, Kawakatsu N, Hayashi K, Kin F, Isogaki T Hypertens Res. 2024; 48(2):796-804.
PMID: 39639128 DOI: 10.1038/s41440-024-02028-4.
Giangregorio F, Mosconi E, Debellis M, Provini S, Esposito C, Garolfi M J Clin Med. 2024; 13(19).
PMID: 39407941 PMC: 11478146. DOI: 10.3390/jcm13195880.
Liu H, Yen C, Jeng W, Hung C, Hsiao C, Tian Y Diagnostics (Basel). 2024; 14(18).
PMID: 39335727 PMC: 11431842. DOI: 10.3390/diagnostics14182048.
Choi H, Park P, Park Y, Huh J, Lee S, Ph D J Rheum Dis. 2023; 30(4):260-267.
PMID: 37736592 PMC: 10509637. DOI: 10.4078/jrd.2023.0032.
Whang J, Park P, Park Y, Huh J, Lee S Front Med (Lausanne). 2023; 10:1217937.
PMID: 37711740 PMC: 10497776. DOI: 10.3389/fmed.2023.1217937.